Evaluating magnetic resonance-guided radiation therapy for solid tumors
Receiving Radiation Therapy in the MRgRT Research Facility
This study is testing a new type of radiation therapy that uses advanced imaging to see if it can improve treatment for people with solid tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT02701712 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the technical performance of a magnetic resonance-guided radiotherapy (MRgRT) facility at the Princess Margaret Cancer Centre. It focuses on how this advanced imaging technology can enhance the workflow of clinical teams while delivering radiation therapy to patients with solid tumors and metastatic lesions. Participants will receive MRgRT as part of their planned clinical intervention, allowing researchers to gather data on its effectiveness and efficiency in a real-world setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled to receive imaging or treatment in the MRgRT facility.
Not a fit: Patients who are not eligible for MRgRT or those who do not require radiation therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the precision and effectiveness of radiation therapy for patients with solid tumors.
How similar studies have performed: Other studies have shown promise with magnetic resonance-guided therapies, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ability to provide informed consent * Planned to receive clinical intervention (imaging or treatment) in the MRgRT facility * At least 18 years of age Exclusion Criteria: -
Where this trial is running
Toronto, Ontario
- University Health Network — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Michael Milosevic, MD — University Health Network, Toronto
- Study coordinator: Michael Milosevic, MD
- Email: mike.milosevic@rmp.uhn.on.ca
- Phone: 416-946-4501
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.